Amarin Corp Plc (AMRN)

[amarininvestor]

They can show that in the study hi Epa/aa levels correlate with lower CVD.
Data is blinded as they don't know for sure is a given patient was on vascepa or changed his/her diet to sushi. But it would give the FDA the science it needs to be more comfortable with the idea as those with the higher epa/aa are more likely to be on vascepa.

Once said that. I am persuaded by other arguments in the board indicating that this scenario has likely not happened. I understand now why it is important to maintain all blinded including for the labs.